Erectile Dysfunction – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Erectile Dysfunction – Drugs In Development, 2024 report and make more profitable business decisions.
Erectile dysfunction (ED) is the inability of a man to have an erection hard enough to have sexual intercourse. It is also known as impotence. The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use, and medications including antidepressants, antihistamines, and medications to treat high blood pressure, pain, or prostate cancer.
The Erectile Dysfunction drugs in development market research report provide comprehensive information on the therapeutics under development for Erectile Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Erectile Dysfunction | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 47 molecules, with 43 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Erectile Dysfunction therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Erectile Dysfunction pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Erectile Dysfunction treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Acerus Pharmaceuticals CorpAquestive Therapeutics Inc
Arovella Therapeutics Ltd
Aspargo Laboratories Inc
Avenir Wellness Solutions Inc
Biozeus Pharmaceutical SA
Can-Fite BioPharma Ltd
Chengdu Dikang Pharmaceuticals Co Ltd
Dicot AB
Evincis Bio Inc
Exopharm Ltd
Humanetics Corp
ILGEN Inc
Initiator Pharma AS
IntelGenx Corp
Jiangsu Hengrui Medicine Co Ltd
Johns Hopkins University
Lexaria Bioscience Corp
LP Pharmaceutical (Xiamen) Co Ltd
Mezzion Pharma Co Ltd
MicroCures Inc
MyX Therapeutics Inc
NAL Pharmaceuticals Ltd
NewG Lab Pharma Inc
Oncotelic Therapeutics Inc
Orgenesis Inc
Palatin Technologies Inc
PeLeMed Co Ltd
Pharmicell Co Ltd
PWC Biomedical Technology Co Ltd
S1 Biopharma Inc
Seelos Therapeutics
Inc.
SGN Nanopharma Inc
Shandong Lukang Pharmaceutical Co Ltd
Shandong University
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Sichuan Baili Pharmaceutical Co Ltd
Targazyme Inc
Techfields Pharma Co Ltd
The United Laboratories International Holdings Ltd
Tritech Biopharmaceuticals Co Ltd
Venturis Therapeutics Inc
Xuanzhu Biotechnology Co Ltd
Yangtze River Pharmaceutical Group
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Erectile Dysfunction reports